SPOTLIGHT: Amgen, Roche square off

Amgen and Roche head into court today to continue their fight over anemia drugs. Roche wants to market Mircera, its treatment for the malady, but Amgen claims the drug violates Amgen patents. Last week, Roche thumbed its nose at Amgen, saying it will sell Mircera as soon as the FDA gives its OK--whether Amgen likes it or not. We'll see whether the court has other ideas. Report